MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Complex movement disorder presentations of autoimmune encephalitis – recovery at 4 weeks versus 4 years

L. Jaffe (Honolulu, USA)

Meeting: 2023 International Congress

Abstract Number: 1983

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis, Dystonia: Etiology and Pathogenesis, NMDA

Category: Other

Objective: The goal is to learn from different presentations of Autoimmune Encephalitis (AIE) so that we consider the diagnosis more quickly, pursue the work-up judiciously and achieve best patient outcomes.  We discuss two very different presentations of movement disorders that both led to recovery but differed significantly in the time to recovery.

Background: Autoimmune Encephalitis often presents with neuropsychiatric symptoms, cognitive deficits, altered level of consciousness, dysautonomia, psychosis and seizures.  Parkinsonism and dystonia are less common presentations and as such, may not prompt an evaluator to consider AIE at initial presentation.  Time to diagnosis has been shown likely most critical for prompt initiation of treatment and start to recovery.  We encountered two patients at the opposite ends of the spectrum of time to diagnosis and treatment initiation and try to learn from their differences and commonalities.

Method: Review of the cases of two young women in our clinic was undertaken.  The first (Patient 1) was initially evaluated elsewhere and presented to us 1 year after onset of symptoms.  The second (Patient 2) presented to our Emergency Department (ED) ten days after a tetanus vaccination and precipitous development of symptoms.

Results: Patient 1 presented one year after onset of focal dystonic limb movements that progressed to a severe choreiform/ballistic disorder, eventually disabling and difficult to work up.  Mild pleocytosis of cerebrospinal fluid was the only diagnostic clue of AIE and treatment with intravenous immunoglobulin (IVIG) was started empirically at 18 months after onset of symptoms.  Recovery evolved over two years and the patient was relieved of all symptoms at 4.5 years after initial onset.  Patient 2 presented to the ED with 4 days of confusion and subtle dystonic limb and facial movements.  A high index of suspicious prompted workup and treatment with sequential high dose steroids and IVIG even  before the confirmatory panel was positive for NMDA-receptor antibodies. All symptoms resolved after 6 weeks of treatment and supportive care.

Conclusion: Two vastly different time courses to diagnosis are presented here to show the complexity with which AIE can present with movement disorders.  A high index of suspicion and move to early treatment is required for prompt recovery but also perseverance and patience for recovery can be rewarded over time.

To cite this abstract in AMA style:

L. Jaffe. Complex movement disorder presentations of autoimmune encephalitis – recovery at 4 weeks versus 4 years [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/complex-movement-disorder-presentations-of-autoimmune-encephalitis-recovery-at-4-weeks-versus-4-years/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/complex-movement-disorder-presentations-of-autoimmune-encephalitis-recovery-at-4-weeks-versus-4-years/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley